Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Narcolepsy Drugs Global Market Report 2025
Request Sample Buy Now
Global Narcolepsy Drugs Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Narcolepsy Drugs Global Market Report 2025

By Type (Narcolepsy With Cataplexy, Narcolepsy Without Cataplexy, Secondary Narcolepsy), By Disease (Daytime Extreme Sleepiness, Cataplexia, Other Diseases), By Therapeutic (Sodium Oxybate, Central Nervous System Stimulants, Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitor, Other Therapeutics) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Narcolepsy Drugs Market Overview

• Narcolepsy Drugs market size has reached to $3.62 billion in 2024

• Expected to grow to $5.52 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%

• Growth Driver: Growing Demand For Personalized Medicine Fuels Narcolepsy Drugs Market Expansion

• Market Trend: Advancements In Extended-Release Therapeutics Revolutionize Narcolepsy Treatment

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Narcolepsy Drugs Market?

Narcolepsy drugs are medications specifically designed to manage and alleviate the symptoms of narcolepsy, a chronic neurological disorder characterized by excessive daytime sleepiness (EDS), sudden episodes of muscle weakness or paralysis (cataplexy), sleep paralysis, and hallucinations. These medications are often used in combination and tailored to the individual needs of the patient, aiming to improve quality of life by reducing the severity of narcolepsy symptoms.

The main types of narcolepsy drugs are narcolepsy with cataplexy, narcolepsy without cataplexy, and secondary narcolepsy. Narcolepsy with Cataplexy is a type of narcolepsy where individuals experience sudden, temporary muscle weakness or paralysis triggered by strong emotions such as laughter, surprise, or anger. The various diseases include daytime extreme sleepiness, cataplexia, and other diseases used by various therapeutics such as sodium oxybate, central nervous system stimulants, tricyclic antidepressants, selective serotonin reuptake inhibitors, and other therapeutics.

Narcolepsy Drugs Market Size and growth rate 2025 to 2029: Graph

What Is The Narcolepsy Drugs Market Size 2025 And Growth Rate?

The narcolepsy drugs market size has grown strongly in recent years. It will grow from $3.62 billion in 2024 to $3.94 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to increased awareness and diagnosis, improved treatment options, regulatory approvals, growing awareness and diagnosis rates, and expansion of healthcare services.

What Is The Narcolepsy Drugs Market Growth Forecast?

The narcolepsy drugs market size is expected to see strong growth in the next few years. It will grow to $5.52 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to the rising prevalence of sleep disorders, advances in personalized medicine, an aging population with increased susceptibility to sleep disorders, increasing enhanced patient support and assistance programs, and expanding healthcare coverage. Major trends in the forecast period include technological innovations, pharmaceutical companies continuing patient-centric approaches, research and development in biologic therapies, innovative drug formulations, and a shift towards non-stimulant alternatives.

The forecast of 8.8% growth over the next five years reflects a modest reduction of 0.8% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could impact U.S. patient care by inflating costs of sodium oxybate production equipment and wake-promoting agent precursors sourced from Italy and Belgium, resulting in treatment interruptions and higher specialty pharmacy costs for sleep disorder patients. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Narcolepsy Drugs Market Segmented?

1) By Type: Narcolepsy With Cataplexy, Narcolepsy Without Cataplexy, Secondary Narcolepsy

2) By Disease: Daytime Extreme Sleepiness, Cataplexia, Other Diseases

3) By Therapeutic: Sodium Oxybate, Central Nervous System Stimulants, Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitor, Other Therapeutics

Subsegments:

1) By Narcolepsy With Cataplexy: Stimulant Medications, Antidepressants, Sodium Oxybate

2) By Narcolepsy Without Cataplexy: Stimulant Medications, Sodium Oxybate, Selective Serotonin And Norepinephrine Reuptake Inhibitors (SNRIs)

3) By Secondary Narcolepsy: Treatment For Underlying Conditions, Stimulants And Other Medications For Symptom Management

What Is Driving The Narcolepsy Drugs Market? Growing Demand For Personalized Medicine Fuels Narcolepsy Drugs Market Expansion

The growing demand for personalized medicine is expected to propel the growth of the narcolepsy drugs market going forward. Personalized medicine refers to a medical care philosophy that aims to tailor medicines and interventions to the particular requirements of each patient. The demand for personalized medicine is due to the rapid growth of omics technology, data integration, genetics, and an awareness of the significance of tailored patient-specific medications and preventive actions. Narcolepsy drugs are used in personalized medicine for tailoring treatment plans to individual patient needs, considering genetic profiles, symptom severity, metabolic rates, and personal preferences to optimize effectiveness and minimize side effects. For instance, according to the Personalized Medicine Coalition, a US-based professional organization, around 12 new customized medications were approved in 2022, accounting for around 34% of all newly approved treatments compared to 2021. Therefore, the growing demand for personalized medicine drives the growth of the narcolepsy drugs industry.

Who Are The Major Players In The Global Narcolepsy Drugs Market?

Major companies operating in the narcolepsy drugs market are Pfizer Inc., Merck & Co. Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB SA, Sun Pharmaceutical Industries Ltd., Jazz Pharmaceutical plc, Ipsen Group, Lundbeck AS, Hikma Pharmaceuticals plc, Lupin Limited, Viatris Inc., Harmony Biosciences Holdings Inc., Ligand Pharmaceuticals Incorporated, Sumitomo Dainippon Pharma Co. Ltd., Avadel Pharmaceuticals plc, Bioprojet Pharma s.a.r.l, Graymark Healthcare Inc., Flamel Technologies SA, Arena Pharmaceuticals

What Are The Key Trends Of The Global Narcolepsy Drugs Market? Advancements In Extended-Release Therapeutics Revolutionize Narcolepsy Treatment

Major companies operating in the narcolepsy drugs market are developing innovative products, such as extended-release therapeutics, to enhance treatment efficacy and patient experience. Extended-release (ER) therapeutics offer significant benefits for patients with narcolepsy by improving medication adherence, maintaining stable drug levels, reducing side effects, and enhancing overall symptom management. For instance, in May 2023, Avadel Pharmaceuticals, an Ireland-based specialty pharmaceutical company, launched Lumryz, an extended-released sodium oxybate medication approved by the Food and Drug Administration (FDA), a US-based federal agency. Lumryz features an innovative extended-release mechanism that allows patients to maintain consistent therapeutic levels overnight with a single dose, enhancing convenience and compliance compared to traditional multiple-dose regimens. This new medication addresses a significant unmet need by simplifying treatment schedules, potentially improving patient adherence and overall quality of life for those managing narcolepsy.

Need data on a specific region in this market?
Request Customisation

What Are Latest Mergers And Acquisitions In The Narcolepsy Drugs Market? Axsome Therapeutics Acquires Sunosi From Jazz Pharmaceuticals To Expand Neuroscience Portfolio

In May 2022, Axsome Therapeutics Inc., a US-based biopharmaceutical company, acquired Sunosi from Jazz Pharmaceuticals for $53 million. With this acquisition, Axsome aims to expand its central nervous system (CNS) portfolio by incorporating Sunosi, a medication designed to improve wakefulness in adults with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea. Jazz Pharmaceuticals plc is an Ireland-based company that manufactures narcolepsy drugs.

What Is The Regional Outlook For The Global Narcolepsy Drugs Market?

North America was the largest region in the narcolepsy drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Narcolepsy Drugs Market?

The narcolepsy drugs market consists of sales of orexin receptor antagonists, stimulants, and orexin-based therapy. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Narcolepsy Drugs Industry?

The narcolepsy drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the narcolepsy drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Narcolepsy Drugs Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $3.94 billion
Revenue Forecast In 2034 $5.52 billion
Growth Rate CAGR of 8.8% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Narcolepsy With Cataplexy, Narcolepsy Without Cataplexy, Secondary Narcolepsy
2) By Disease: Daytime Extreme Sleepiness, Cataplexia, Other Diseases
3) By Therapeutic: Sodium Oxybate, Central Nervous System Stimulants, Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitor, Other Therapeutics Subsegments: 1) By Narcolepsy With Cataplexy: Stimulant Medications, Antidepressants, Sodium Oxybate
2) By Narcolepsy Without Cataplexy: Stimulant Medications, Sodium Oxybate, Selective Serotonin And Norepinephrine Reuptake Inhibitors (SNRIs)
3) By Secondary Narcolepsy: Treatment For Underlying Conditions, Stimulants And Other Medications For Symptom Management
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Merck & Co. Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB SA, Sun Pharmaceutical Industries Ltd., Jazz Pharmaceutical plc, Ipsen Group, Lundbeck AS, Hikma Pharmaceuticals plc, Lupin Limited, Viatris Inc., Harmony Biosciences Holdings Inc., Ligand Pharmaceuticals Incorporated, Sumitomo Dainippon Pharma Co. Ltd., Avadel Pharmaceuticals plc, Bioprojet Pharma s.a.r.l, Graymark Healthcare Inc., Flamel Technologies SA, Arena Pharmaceuticals
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Narcolepsy Drugs Market Characteristics

3. Narcolepsy Drugs Market Trends And Strategies

4. Narcolepsy Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Narcolepsy Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Narcolepsy Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Narcolepsy Drugs Market Growth Rate Analysis

5.4. Global Narcolepsy Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Narcolepsy Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Narcolepsy Drugs Total Addressable Market (TAM)

6. Narcolepsy Drugs Market Segmentation

6.1. Global Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Narcolepsy With Cataplexy

Narcolepsy Without Cataplexy

Secondary Narcolepsy

6.2. Global Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Daytime Extreme Sleepiness

Cataplexia

Other Diseases

6.3. Global Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Sodium Oxybate

Central Nervous System Stimulants

Tricyclic Antidepressants

Selective Serotonin Reuptake Inhibitor

Other Therapeutics

6.4. Global Narcolepsy Drugs Market, Sub-Segmentation Of Narcolepsy With Cataplexy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Stimulant Medications

Antidepressants

Sodium Oxybate

6.5. Global Narcolepsy Drugs Market, Sub-Segmentation Of Narcolepsy Without Cataplexy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Stimulant Medications

Sodium Oxybate

Selective Serotonin And Norepinephrine Reuptake Inhibitors (SNRIs)

6.6. Global Narcolepsy Drugs Market, Sub-Segmentation Of Secondary Narcolepsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Treatment For Underlying Conditions

Stimulants And Other Medications For Symptom Management

7. Narcolepsy Drugs Market Regional And Country Analysis

7.1. Global Narcolepsy Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Narcolepsy Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Narcolepsy Drugs Market

8.1. Asia-Pacific Narcolepsy Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Narcolepsy Drugs Market

9.1. China Narcolepsy Drugs Market Overview

9.2. China Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Narcolepsy Drugs Market

10.1. India Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Narcolepsy Drugs Market

11.1. Japan Narcolepsy Drugs Market Overview

11.2. Japan Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Narcolepsy Drugs Market

12.1. Australia Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Narcolepsy Drugs Market

13.1. Indonesia Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Narcolepsy Drugs Market

14.1. South Korea Narcolepsy Drugs Market Overview

14.2. South Korea Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Narcolepsy Drugs Market

15.1. Western Europe Narcolepsy Drugs Market Overview

15.2. Western Europe Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Narcolepsy Drugs Market

16.1. UK Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Narcolepsy Drugs Market

17.1. Germany Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Narcolepsy Drugs Market

18.1. France Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Narcolepsy Drugs Market

19.1. Italy Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Narcolepsy Drugs Market

20.1. Spain Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Narcolepsy Drugs Market

21.1. Eastern Europe Narcolepsy Drugs Market Overview

21.2. Eastern Europe Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Narcolepsy Drugs Market

22.1. Russia Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Narcolepsy Drugs Market

23.1. North America Narcolepsy Drugs Market Overview

23.2. North America Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Narcolepsy Drugs Market

24.1. USA Narcolepsy Drugs Market Overview

24.2. USA Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Narcolepsy Drugs Market

25.1. Canada Narcolepsy Drugs Market Overview

25.2. Canada Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Narcolepsy Drugs Market

26.1. South America Narcolepsy Drugs Market Overview

26.2. South America Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Narcolepsy Drugs Market

27.1. Brazil Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Narcolepsy Drugs Market

28.1. Middle East Narcolepsy Drugs Market Overview

28.2. Middle East Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Narcolepsy Drugs Market

29.1. Africa Narcolepsy Drugs Market Overview

29.2. Africa Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Narcolepsy Drugs Market Competitive Landscape And Company Profiles

30.1. Narcolepsy Drugs Market Competitive Landscape

30.2. Narcolepsy Drugs Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Narcolepsy Drugs Market Other Major And Innovative Companies

31.1. UCB SA

31.2. Sun Pharmaceutical Industries Ltd.

31.3. Jazz Pharmaceutical plc

31.4. Ipsen Group

31.5. Lundbeck AS

31.6. Hikma Pharmaceuticals plc

31.7. Lupin Limited

31.8. Viatris Inc.

31.9. Harmony Biosciences Holdings Inc.

31.10. Ligand Pharmaceuticals Incorporated

31.11. Sumitomo Dainippon Pharma Co. Ltd.

31.12. Avadel Pharmaceuticals plc

31.13. Bioprojet Pharma s.a.r.l

31.14. Graymark Healthcare Inc.

31.15. Flamel Technologies SA

32. Global Narcolepsy Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Narcolepsy Drugs Market

34. Recent Developments In The Narcolepsy Drugs Market

35. Narcolepsy Drugs Market High Potential Countries, Segments and Strategies

35.1 Narcolepsy Drugs Market In 2029 - Countries Offering Most New Opportunities

35.2 Narcolepsy Drugs Market In 2029 - Segments Offering Most New Opportunities

35.3 Narcolepsy Drugs Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Narcolepsy Drugs Market, Sub-Segmentation Of Narcolepsy With Cataplexy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Narcolepsy Drugs Market, Sub-Segmentation Of Narcolepsy Without Cataplexy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Narcolepsy Drugs Market, Sub-Segmentation Of Secondary Narcolepsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Narcolepsy Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Narcolepsy Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Pfizer Inc. Financial Performance
  • Table 78: Merck & Co. Inc. Financial Performance
  • Table 79: Sanofi S.A. Financial Performance
  • Table 80: Takeda Pharmaceutical Company Limited Financial Performance
  • Table 81: Teva Pharmaceutical Industries Ltd. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Narcolepsy Drugs Market, Sub-Segmentation Of Narcolepsy With Cataplexy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Narcolepsy Drugs Market, Sub-Segmentation Of Narcolepsy Without Cataplexy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Narcolepsy Drugs Market, Sub-Segmentation Of Secondary Narcolepsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Narcolepsy Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Narcolepsy Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Narcolepsy Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Narcolepsy Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Narcolepsy Drugs Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Pfizer Inc. Financial Performance
  • Figure 78: Merck & Co. Inc. Financial Performance
  • Figure 79: Sanofi S.A. Financial Performance
  • Figure 80: Takeda Pharmaceutical Company Limited Financial Performance
  • Figure 81: Teva Pharmaceutical Industries Ltd. Financial Performance

Latest Market Developments in Ketamine Clinic Industry: Forecast 2025–2029

Read More About Latest Market Developments in Ketamine Clinic Industry: Forecast 2025–2029

Competitive and Market Trend Analysis of Lifestyle Diseases Apps Industry Through 2029

Read More About Competitive and Market Trend Analysis of Lifestyle Diseases Apps Industry Through 2029

Industry Trends Show Locum Tenens Staffing Market Set to Expand at 11.6% CAGR Until 2029

Read More About Industry Trends Show Locum Tenens Staffing Market Set to Expand at 11.6% CAGR Until 2029

In-Depth Lung Cancer Surgery Market Report: Business Trends, Growth Factors, and Forecast to 2029

Read More About In-Depth Lung Cancer Surgery Market Report: Business Trends, Growth Factors, and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Read More About Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Central Nervous System Drugs Global Market Report 2022 – By Type (Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route O...

View Report

Cell Banking Outsourcing Global Market Report 2025 – By Type (Master Cell Banking, Working Cell Banking, Viral Cell Banking), By Cell Type (Stem Cell Banking, Non-Stem Cell Banking), By Phase (Bank Storage, Bank Characte...

View Report

Terminal Tractor Global Market Report 2025 – By Type (Manual, Automated), By Propulsion (Diesel, Compressed Natural Gas (CNG), Hybrid, Electric), By Tonnage (Less Than 50 Ton, 50-100 Ton, Greater Than 100 Ton), By Axle (...

View Report

Thiamine Global Market Report 2025 – By Product Type (Thiamine Mononitrate, Thiamine Hydrochloride, Thiamine Pyrophosphate), By Form (Tablets And Capsules, Liquid, Powder), By Application (Food And Beverages, Pharmaceuti...

View Report

Solar Pile Global Market Report 2025 – By Type (Ground-Mounted Piles, Helical Piles Or Screw Piles, Driven Piles), By Material (Steel, Aluminum, Other Materials), By Application (Utility, Residential, Commercial, Industr...

View Report

Vendor Risk Management Global Market Report 2025 – By Component (Solution, Services), By Deployment Mode (Cloud, On-Premises), By Organization Size (Small And Medium-Sized Enterprises, Large Enterprises), By Verticals (B...

View Report

Gastrointestinal Drugs Market 2022 - By Type (Antacids, Antiulcerants, Antiemetics and Antinauseants, Antidiarrheals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Root of Administrat...

View Report

Frequently Asked Questions

Narcolepsy drugs are medications specifically designed to manage and alleviate the symptoms of narcolepsy, a chronic neurological disorder characterized by excessive daytime sleepiness (EDS), sudden episodes of muscle weakness or paralysis (cataplexy), sleep paralysis, and hallucinations. These medications are often used in combination and tailored to the individual needs of the patient, aiming to improve quality of life by reducing the severity of narcolepsy symptoms. For further insights on this market, request a sample here

The market major growth driver - Growing Demand For Personalized Medicine Fuels Narcolepsy Drugs Market Expansion. For further insights on this market, request a sample here

The narcolepsy drugs market size has grown strongly in recent years. It will grow from $3.62 billion in 2024 to $3.94 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to increased awareness and diagnosis, improved treatment options, regulatory approvals, growing awareness and diagnosis rates, and expansion of healthcare services. The narcolepsy drugs market size is expected to see strong growth in the next few years. It will grow to " $5.52 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to the rising prevalence of sleep disorders, advances in personalized medicine, an aging population with increased susceptibility to sleep disorders, increasing enhanced patient support and assistance programs, and expanding healthcare coverage. Major trends in the forecast period include technological innovations, pharmaceutical companies continuing patient-centric approaches, research and development in biologic therapies, innovative drug formulations, and a shift towards non-stimulant alternatives. For further insights on this market, request a sample here

The narcolepsy drugsmarket covered in this report is segmented –
1) By Type: Narcolepsy With Cataplexy; Narcolepsy Without Cataplexy; Secondary Narcolepsy
2) By Disease: Daytime Extreme Sleepiness; Cataplexia; Other Diseases
3) By Therapeutic: Sodium Oxybate; Central Nervous System Stimulants; Tricyclic Antidepressants; Selective Serotonin Reuptake Inhibitor; Other Therapeutics Subsegments:
1) By Narcolepsy With Cataplexy: Stimulant Medications; Antidepressants; Sodium Oxybate
2) By Narcolepsy Without Cataplexy: Stimulant Medications; Sodium Oxybate; Selective Serotonin And Norepinephrine Reuptake Inhibitors (SNRIs)
3) By Secondary Narcolepsy: Treatment For Underlying Conditions; Stimulants And Other Medications For Symptom Management For further insights on this market, request a sample here

North America was the largest region in the narcolepsy drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the narcolepsy drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the narcolepsy drugs market are Pfizer Inc., Merck & Co. Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB SA, Sun Pharmaceutical Industries Ltd., Jazz Pharmaceutical plc, Ipsen Group, Lundbeck AS, Hikma Pharmaceuticals plc, Lupin Limited, Viatris Inc., Harmony Biosciences Holdings Inc., Ligand Pharmaceuticals Incorporated, Sumitomo Dainippon Pharma Co. Ltd., Avadel Pharmaceuticals plc, Bioprojet Pharma s.a.r.l, Graymark Healthcare Inc., Flamel Technologies SA, Arena Pharmaceuticals. For further insights on this market, request a sample here.

Major trends in this market include Advancements In Extended-Release Therapeutics Revolutionize Narcolepsy Treatment. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Narcolepsy Drugs Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon